Biography
Dr Muzaffer Kaser is an affiliated assistant professor at the Department of Psychiatry, University of Cambridge. He is a consultant psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust. He has been the lead consultant for the establishment of the Staff Mental Health Service, a bespoke mental health clinic for NHS staff in Cambridgeshire that serves over 25,000 healthcare workers. The Staff Mental Health Service (SMHS) provides rapid access to assessments and treatments from a multidisciplinary mental health team. Dr Kaser is the Principal Investigator for the health economics evaluation study of the SMHS, investigating the cost implications of this innovative model.
His experimental research has focused on the mechanisms and treatments of neurocognitive problems associated with psychiatric conditions. Currently, Dr Kaser is the Clinical PI for Cambridge site of the MRC funded Psychosis Immune Mechanisms Stratified Study (PIMS). PIMS aims to investigate the role of inflammation in understanding psychotic symptoms, apathy, and cognition in psychosis.
Dr Kaser trained in psychiatry in Istanbul and in Cambridge. He specialises in general adult psychiatry and liaison psychiatry. He did an MPhil in Translational Medicine and a PhD at the University of Cambridge where he also has worked as NIHR clinical lecturer.
Currently, Dr Kaser is the Mental Health Specialty Lead for East of England at the NIHR Regional Research Delivery Network.
Dr Kaser is a bye-fellow and professional advisor to tutors at Emmanuel College, Cambridge where he teaches 2nd year medical students. He regularly teaches clinical medical students and keen to offer supervision for any SSC projects. He is a member of the Occupational Psychiatry Special Interest Group executive committee and a member of the Wellbeing Committee at the Royal College of Psychiatrists.
Publications
1. Kaser M, Foley ÉM, Khandaker GM. Neurocognitive performance in depressed patients with low-grade inflammation and somatic symptoms. Brain, Behavior, & Immunity-Health. 2022 Feb 1;19:100409.
2. Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ. Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study. Biological psychiatry. Cognitive Neuroscience and Neuroimaging. 2017 Mar 1;2(2):115-22.
3. Kaser M, Zaman R, Sahakian BJ. Cognition as a treatment target in depression. Psychological medicine. 2017 Apr;47(6):987-9.
4. Kaser M, Soltesz F, Lawrence P, Miller S, Dodds C, Croft R, Dudas RB, Zaman R, Fernandez-Egea E, Müller U, Dean A. Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia. PloS one. 2013 Dec 17;8(12):e83255.
5. Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. The Journal of clinical psychiatry. 2013 Nov 15;74(11):12096.